A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease

Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) show a large overlap in clinical presentation, which presents diagnostic challenges. As a consequence, invasive and burdensome endoscopies are often used to distinguish between IBD and IBS. Here, we aimed to develop a noninvasive fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gacesa, R., Vich Vila, A., Collij, V., Mujagic, Z., Kurilshikov, A., Voskuil, M.D., Festen, E.A.M., Wijmenga, C., Jonkers, D.M.A.E., Dijkstra, G., Fu, J., Zhernakova, A., Imhann, F., Weersma, R.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317932/
https://www.ncbi.nlm.nih.gov/pubmed/34313538
http://dx.doi.org/10.1080/19490976.2021.1943288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317932/
https://www.ncbi.nlm.nih.gov/pubmed/34313538
http://dx.doi.org/10.1080/19490976.2021.1943288

Ejemplares similares